Search

everythinglearnresearchcommunity

for

Search:↓

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Treatments for hair loss include estrogen therapy and special shampoos.

Minoxidil helps lower severe blood pressure and promotes hair growth but can have serious side effects and must be used continuously.

ADSC-CM treatment improved hair density and thickness in women with hair loss, safely and effectively.

Certain proteins are found at higher levels in balding areas compared to non-balding areas, suggesting a link to hair loss. This could be useful for diagnosing and treating hair loss.

Parthenolide promotes hair growth in mice and may influence pathways related to male pattern baldness.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Most Hairless gene mutations reduce its ability to work with the Vitamin D Receptor, which might explain a certain type of hair loss.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Emerging therapies like stem cell and laser treatments show promise for hair regeneration.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

Creating fully functional artificial skin for chronic wounds is still very challenging.

The polyherbal hair oil effectively treats hair problems with fewer side effects.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Adipose-derived stem cells show promise for cosmetic treatments but need more research.

Nanoemulsions improve stability and delivery of active ingredients in cosmetics for skin and hair care.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Cannabidiol shows promise as an effective treatment for acne.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Targeting the Smoothened receptor shows promise for treating certain cancers.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

JAK inhibitors show promise for treating various skin diseases.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.